Articles From: Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Medifast, Inc. Stockholders to Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors


2014/12/16
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Medifast, Inc. (“Medifast” or the “Company”) (NYSE:MED) concerning the improper compensation of the Company’s executives.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Medifast, Inc. Stockholders investment picks
2014/12/16
Cerus Corporation (NASDAQ: CERS) today announced that the U.S. Food and Drug Administration (FDA) has approved the INTERCEPT Blood System for plasma.
Sign-up for FDA Approves INTERCEPT Blood System for Plasma investment picks
2014/12/16
http://www.marketwire.com/library/MwGo/2014/12/16/11G028708/Extendicare_Inc.-1387207530938.jpg MARKHAM, ON--(Marketwired - December 16, 2014) - Extendicare Inc. ("Extendicare" or the "Company") (TSX: EXE) today announced its intention, subject to the approval of the Toronto Stock Exchange (the "TSX"), to purchase for cancellation up to 10% of the public float of its common shares (the "Common Shares") over a maximum 12-month period, under a normal course issuer bid (the "Bid"). The Company intends to file a notice of intention with the TSX in this regard.
Sign-up for Extendicare Announces Intention to Issue Normal Course Issuer Bid for up to 10% of Public Float investment picks
2014/12/16
- Authorizes the Repurchase of Convertible Notes - GREENWICH, Conn.
Sign-up for Starwood Property Trust Announces Expansion of Share Repurchase Program investment picks
2014/12/16
By Tomi Kilgore, MarketWatch Oracle has missed profit, sales forecasts the past three quarters Investors will be waiting anxiously to see if Oracle Corp.
Sign-up for UPDATE: What to expect from Oracle's earnings investment picks
2014/12/16
GREENWICH, CT --
Sign-up for Oxford Lane Capital Corp. Sends Notice to Shareholders Regarding Stock Repurchase Program investment picks
2014/12/16
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it will now report fourth quarter and full year 2014 financial results prior to the market opening on Monday, December 22, 2014.
Sign-up for Bioanalytical Systems to Release Fourth Quarter Fiscal 2014 Results on Monday December 22, 2014; Conference Call & Webcast Set For 11:00 a.m. EST investment picks
2014/12/16
By Lauren Pollock Apprarel company's founder had been suspended since June for alleged misconduct American Apparel Inc. said it officially terminated the employment of Chief Executive Dov Charney and has named veteran fashion executive Paula Schneider as his successor.
Sign-up for American Apparel officially terminates CEO Charney's employment investment picks
2014/12/16
BankUnited, Inc. (NYSE:BKU) today announced that its Board of Directors has declared a quarterly cash dividend of $0.21 per common share.
Sign-up for BankUnited, Inc. Announces Quarterly Dividend investment picks
2014/12/16
Dejour Energy Inc. (NYSE MKT: DEJ / TSX: DEJ) (“Dejour” or the “Company”), an independent oil and natural gas exploration and production company operating in North America's Piceance Basin and Peace River Arch regions, updates current development progress underway at the Woodrush/Hunter Project (“Woodrush”) in NE B.C .
Sign-up for Dejour Discovery Nets 38’ Combined Pay at Woodrush investment picks
2014/12/16
MINNEAPOLIS , Dec.
Sign-up for General Mills Board Of Directors Declares Quarterly Dividend investment picks
2014/12/16
http://media3.marketwire.com/logos/20130114-c114a.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for CounterPath Receives Notification From NASDAQ Relating to Non-Compliance With Minimum Bid Price Requirement investment picks
2014/12/16
http://www.ccnmatthews.com/logos2/car020903.jpg TORONTO, ONTARIO --
Sign-up for CAPREIT Announces December 2014 Distribution investment picks
2014/12/16
SeaWorld Entertainment Inc. (SEAS) announced plans Tuesday to postpone its regular fourth quarter dividend to January, citing debt covenants.
Sign-up for UPDATE: SeaWorld postpones quarterly dividend investment picks
2014/12/16
LANCASTER, N.Y., Dec.
Sign-up for Ecology and Environment, Inc., First Quarter Earnings Improve vs. Last Year investment picks
2014/12/16
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- Tesla shares ended Tuesday at $197.81, their lowest close since May 20.
Sign-up for Tesla closes below $200 investment picks
2014/12/16
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Middle District of Florida on behalf of purchasers of Rayonier, Inc. (“Rayonier” or the “Company”) (NYSE: RYN) securities during the period between January 27, 2014 and November 7, 2014, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until January 12, 2015 to seek appointment as lead plaintiff.
Sign-up for Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Rayonier, Inc. To Contact Brower Piven Before The January 12, 2015 Lead Plaintiff Deadline In Class Action Lawsuit investment picks
2014/12/16
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch Russia hikes rates to 17%, stocks collapse NEW YORK (MarketWatch) -- The U.S. stock market suffered some of its most violent price swings since mid-October on Tuesday, as investors wrestled with volatility in oil and growing turmoil in Russia, exemplified by a spectacular decline of the ruble.
Sign-up for UPDATE: U.S. stocks wrap wild trading day sharply lower investment picks
2014/12/16
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Western District of Texas on behalf of purchasers of Hanger, Inc. (“Hanger” or the “Company”) (NYSE: HGR) securities during the period between August 1, 2013 and August 7, 2014, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until January 12, 2015 to seek appointment as lead plaintiff.
Sign-up for SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Hanger, Inc. to Contact Brower Piven before the January 12, 2015 Lead Plaintiff Deadline in Class Action Lawsuit investment picks
2014/12/16
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of New York on behalf of purchasers of Albany Molecular Research, Inc. (“Albany Molecular” or the “Company”) (Nasdaq: AMRI) common stock during the period between August 5, 2014 and November 5, 2014, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until January 12, 2015 to seek appointment as lead plaintiff.
Sign-up for SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Albany Molecular Research, Inc. To Contact Brower Piven Before The January 12, 2015 Lead Plaintiff Deadline In Class Action Lawsuit investment picks
2014/12/16
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1165433&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Standard & Poor's Upgrades JLL's Investment-Grade Credit Rating investment picks
2014/12/16
IMS Health (NYSE:IMS) today announced that Mason Tenaglia has been appointed vice president, Payer & Managed Care Insights, IMS Institute for Healthcare Informatics, a new position.
Sign-up for IMS Health Names Mason Tenaglia Vice President, Payer & Managed Care Insights, IMS Institute for Healthcare Informatics investment picks
2014/12/16
Iron Mountain Incorporated (NYSE: IRM), the storage and information management services company, announced that it has called for redemption $306 million of the aggregate principal amount outstanding of its $412 million 8-3/8% Senior Subordinated Notes due 2021 (the “2021 Notes”), in accordance with the Indenture governing these notes.
Sign-up for Iron Mountain Incorporated to Call a Portion of 8-3/8% Subordinated Notes due 2021 for Redemption investment picks
2014/12/16
Ipsen Biopharmaceuticals, Inc. , an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), today announced that Somatuline ® Depot ® (lanreotide) Injection 120 mg (referred to as Somatuline ® ) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, well or moderately differentiated, locally advanced or metastatic disease to improve progression-free survival (PFS). “The approval of Somatuline ® for the treatment of patients living with gastrointestinal and pancreatic tumors is a major achievement for Ipsen that will provide a new therapeutic option with the potential to help many of the thousands of patients in the United States suffering from this devastating disease,” said Cynthia Schwalm, President and CEO of Ipsen
Sign-up for Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Medifast, Inc. Stockholders to Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent